Article 11320

Title of the article

PROARHYTHMIC EFFECTS OF DOXORUBICIN (LITERATURE REVIEW) 

Authors

Chaulin Aleksey Mikhaylovich, Assistant, sub-department of histology and embryology, Samara State Medical University (89 Chapayevskaya street, Samara, Russia); doctor, Samara Regional Clinical Cardiology Dispensary (43 Aerodromnaya street, Samara, Russia), E-mail: alekseymichailovich22976@gmail.com
Grigor'eva Yuliya Vladimirovna, Doctor of medical sciences, associate professor, sub-department of histology and embryology, Samara State Medical University (89 Chapaevskaya street, Samara, Russia), E-mail: histology@bk.ru 

Index UDK

616.12-008.318-092(075.8) 

DOI

10.21685/2072-3032-2020-3-11 

Abstract

For the treatment of oncological diseases, a fairly extensive Arsenal of effective chemotherapeutic drugs is used. One of the most widely used drugs is doxorubicinan anthracycline antibiotic with pronounced antitumor activity. The antitumor properties of doxorubicin are based on several main mechanisms: intercalation (insertion) into the DNA and inhibition of topoisomerase II, which leads to a violation of DNA synthesis and repair. Doxorubicin also contains a quinone fragment that participates in redox reactions with certain intracellular molecules, which leads to the formation of reactive oxygen species. The oxidative stress that occurs when doxorubicin is administered also causes the development of adverse cardiotoxic effects that disrupt the contractile function of the myocardium, which ultimately leads to chronic heart failure. To date, there are a significant number of review articles describing doxorubicin-induced heart failure, but there is not enough information about the relationship between doxorubicin and cardiac arrhythmias. This review discusses the proarrhythmic effects of doxorubicin and the pathophysiological mechanisms underlying them: the effect of doxorubicin on cardiac action potential, dynamics of intracellular calcium concentration, and cardiac ion currents. 

Key words

doxorubicin, anthracyclines, cardiotoxicity, cardiac arrhythmias, pathophysiology, reactive oxygen species 

Download PDF
References

1. Tacar O., Sriamornsak P., Dass C. R. The Journal Pharmacy and Pharmacology. 2013, vol. 65 (2), pp. 157–170. DOI 10.1111/j.2042-7158.2012.01567.x.
2. Rukavitsyn O. A., Pop V. P. Onkogematologiya [Oncohematology]. 2008, vol. 3 (1-2), pp. 75‒84. Available at: https://www.elibrary.ru/item.asp?id=15101153 [In Russian]
3. Geisberg C. A., Sawyer D. B. Curr Hypertens Rep. 2010, vol. 12, pp. 404–410. DOI 10.1007/s11906-010-0146-y.
4. Armstrong G. T., Liu Q., Yasui Y., Neglia J. P., Leisenring W., Robison L. L., Mertens A. C. Journal of Clinical Oncology. 2009, vol. 27 (14), pp. 2328‒2338. DOI 10.1200/jco.2008.21.1425.
5. Swain S. M., Whaley F. S., Ewer M. S. Cancer. 2003, vol. 97 (11), pp. 2869‒2879. DOI 10.1002/cncr.11407.
6. Cardinale D., Iacopo F., Cipolla C. M. Front Cardiovasc Med. 2020, vol. 7, p. 26. DOI 10.3389/fcvm.2020.00026.
7. Seliverstova D. V., Evsina O. V. Serdtse: zhurnal dlya praktikuyushchikh vrachey [Heart: journal for medical practitioners]. 2016, vol. 15 (1), pp. 50‒57. DOI 10.18087/rhj.2016.1.2115. [In Russian]
8. Adamcova M., Sterba M., Simunek T., Potacova A., Popelova O., Mazurova Y., Gersl V. Expert Opin Drug Saf. 2005, vol. 4 (3), pp. 457‒472. DOI 10.1517/14740338.4.3.457.
9. Jones M., O'Gorman P., Kelly C., Mahon N., Fitzgibbon M. C. Annals of Clinical Biochemistry. 2017, vol. 54 (1), pp. 149‒157. DOI 10.1177/0004563216650464.
10. Chaulin A. M., Karslyan L. S., Grigor'eva E. V., Nurbaltaeva D. A., Duplyakov D. V. Kardiologiya [Cardiology]. 2019, vol. 59 (11), pp. 66‒75. DOI:10.18087/cardio.2019.11.n414. [In Russian]
11. Chaulin A. M., Duplyakov D. V. Kardiologiya: novosti, mneniya, obuchenie [Cardiology: news, opinions, training]. 2019, vol. 7 (2), pp. 13‒23. DOI 10.24411/2309-1908-2019-12002. [In Russian]
12. Chaulin A. M., Duplyakov D. V. Kardiologiya: novosti, mneniya, obuchenie [Cardiology: news, opinions, training]. 2019, vol. 7 (2), pp. 24‒35. DOI 10.24411/2309-1908-2019-12003. [In Russian]
13. Matyash M. G., Kravchuk T. L., Vysotskaya V. V., Chernov V. I., Gol'dberg V. E. Sibirskiy onkologicheskiy zhurnal [Siberian oncological journal]. 2008, no. 6 (30), pp. 66‒75. [In Russian]
14. Vatutin N. T., Sklyannaya E. V., El'-Khatib M. A., Taradin G. G. Rossiyskiy onkologicheskiy zhurnal [Russian oncological journal]. 2017, vol 22 (6), pp. 345–350. DOI http://dx.doi.org/10.18821/1028-9984-2017-22-6-345-350. [In Russian]
15. Feyskhanova L. I., Malov A. A., Kharisova E. Kh. Zhurnal Serdechnaya Nedostatochnost' [Heart Failure Journal]. 2015, vol. 16 (5), pp. 296–302. DOI 10.18087/rhfj.2015.5.2109. [In Russian]
16. Amin A. S., Tan H. L., Wilde A. A. Heart Rhythm. 2010, vol. 7 (1), pp. 117‒126. DOI 10.1016/j.hrthm.2009.08.005.
17. Antzelevitch C., Burashnikov A. Cardiac Electrophysiology Clinics. 2011, vol. 3 (1), pp. 23‒45. DOI 10.1016/j.ccep.2010.10.012.
18. Jensen R. A., Acton E. M., Peters J. H. Journal of Cardiovascular Pharmacology. 1984, vol. 6 (1), pp. 186‒200. Available at: https://www.ncbi.nlm.nih.gov/pubmed/6199603.
19. Milberg P., Fleischer D., Stypmann J., Osada N., Monnig G., Engelen M. A., Bruch C., Breithardt G., Haverkamp W., Eckardt L. Basic Research in Cardiology. 2007, vol. 102 (1), pp. 42‒51. DOI 10.1007/s00395-006-0609-0.
20. Ducroq J., Moha ou Maati H., Guilbot S., Dilly S., Laemmel E., Pons-Himbert C., Faivre J. F., Bois P., Stücker O., Le Grand M. British Journal of Pharmacology. 2010, vol. 159 (1), pp. 93‒101. DOI 10.1111/j.1476-5381.2009.00371.x.
21. Agen C., Bernardini N., Danesi R., Della Torre P., Costa M., Del Tacca M. Cancer Chemotherapy and Pharmacology. 1992, vol. 30 (2), pp. 95‒99. DOI 10.1007/bf00686399.
22. Xin Y., Zhang S., Gu L., Liu S., Gao H., You Z., Zhou G., Wen L., Yu J., Xuan Y. Biological & Pharmaceutical Bulletin. 2011, vol. 34 (10), pp. 1523‒1526. DOI 10.1248/bpb.34.1523.
23. Pecoraro M., Rodríguez-Sinovas A., Marzocco S., Ciccarelli M., Iaccarino G., Pinto A., Popolo A. International Journal of Molecular Sciences. 2017, vol. 18 (10), p. E2121. DOI 10.3390/ijms18102121.
24. Poelzing S., Rosenbaum D. S. American Journal of Physiology. Heart and Circulatory Physiology. 2004, vol. 287 (4), pp. 1762‒1770. DOI 10.1152/ajpheart.00346.2004.
25. Larsen R. L., Jakacki R. I., Vetter V. L., Meadows A. T., Silber J. H., Barber G. The American Journal of Cardiology. 1992, vol. 70 (1), pp. 73‒77. DOI 10.1016/0002-9149(92)91393-i.
26. Kilickap S., Barista I., Akgul E., Aytemir K., Aksoy S., Tekuzman G. Southern Medical Journal. 2007, vol. 100 (3), pp. 262‒265. DOI 10.1097/01.smj.0000257382. 89910.fe.
27. Raabe N. K., Storstein L. Acta Oncol. 1991, vol. 30 (7), pp. 843‒846. DOI 10.3109/02841869109091832.
28. Amioka M., Sairaku A., Ochi T., Okada T., Asaoku H., Kyo T., Kihara Y. The American Journal of Cardiology. 2016, vol. 118 (9), pp. 1386‒1389. DOI 10.1016/j.amjcard.2016.07.049.
29. Kilickap S., Akgul E., Aksoy S., Aytemir K., Barista I. Europace. 2005, vol. 7 (3), pp. 227‒230. DOI 10.1016/j.eupc.2004.12.012.
30. Rudzinski T., Ciesielczyk M., Religa W., Bednarkiewicz Z., Krzeminska-Pakula M. Europace. 2007, vol. 9 (5), pp. 278‒280. DOI 10.1093/europace/eum033.
31. Pye M. P., Cobbe S. M. Cardiovascular Research. 1996, vol. 32 (2), pp. 248‒257. DOI 10.1016/0008-6363(96)00080-6.
32. He L., Xiao J., Fu H., Du G., Xiao X., Zhang C., Gu Y., Ma Y. Journal of Huazhong University of Science and Technology. Medical Sciences. 2012, vol. 32 (3), pp. 334‒339. DOI 10.1007/s11596-012-0058-y.
33. Venditti P., Balestrieri M., De Leo T., Di Meo S. Cardiovascular Research. 1998, vol. 38 (3), pp. 695‒702. DOI 10.1016/s0008-6363(98)00034-0.
34. Lazarus M. L., Rossner K. L., Anderson K. M. Cardiovascular Research. 1980, vol. 14 (8), pp. 446‒450. DOI 10.1093/cvr/14.8.446.
35. Binah O., Cohen I. S., Rosen M. R. Circulation Research. 1983, vol. 53 (5), pp. 555‒562. DOI 10.1161/01.res.53.5.655.
36. Wang Y. X., Korth M. Circulation Research. 1995, vol. 76 (4), pp. 645‒653. DOI 10.1161/01.res.76.4.645.
37. Shenasa H., Calderone A., Vermeulen M., Paradis P., Stephens H., Cardinal R., de Champlain J., Rouleau J. L. Cardiovascular Research. 1990, vol. 24 (7), pp. 591‒604. DOI 10.1093/cvr/24.7.591.
38. Wagner S., Rokita A. G., Anderson M. E., Maier L. S. Antioxid Redox Signal. 2013, vol. 18 (9), pp. 1063‒1077. DOI 10.1089/ars.2012.4818.
39. Bers D. M. Nature. 2002, vol. 415 (6868), pp. 198‒205. DOI 10.1038/415198a.
40. Sag C. M., Kohler A. C., Anderson M. E., Backs J., Maier L. S. Journal of Molecular and Cellular Cardiology. 2011, vol. 51 (5), pp. 749‒759. DOI 10.1016/j.yjmcc.2011.07.016.
41. Kim S. Y, Kim S. J., Kim B. J., Rah S. Y., Chung S. M., Im M. J., Kim U. H. Experimental & Molecular Medicine. 2006, vol. 38 (5), pp. 535‒545. DOI 10.1038/emm.2006.63.
42. Llach A., Mazevet M., Mateo P., Villejouvert O., Ridoux A., Rucker-Martin C., Ribeiro M., Fischmeister R., Crozatier B., Benitah J. P., Morel E., Gómez A. M. Journal of Molecular and Cellular Cardiology. 2019, vol. 126, pp. 129‒139. DOI 10.1016/j.yjmcc.2018.11.019.
43. Boucek R. J. Jr., Miracle A., Anderson M., Engelman R., Atkinson J., Dodd D. A. Journal of Molecular and Cellular Cardiology. 1999, vol. 31 (8), pp. 1435‒1446. DOI 10.1006/jmcc.1999.0972.
44. Olson R. D., Gambliel H. A., Vestal R. E., Shadle S. E., Charlier H. A. Jr., Cusack B. J. Cardiovascular Toxicology. 2005, vol. 5 (3), pp. 269‒283. DOI 10.1385/ct:5:3:269.
45. Arai M., Tomaru K., Takizawa T., Sekiguchi K., Yokoyama T., Suzuki T., Nagai R. Journal of Molecular and Cellular Cardiology. 1998, vol. 30 (2), pp. 243‒254. DOI 10.1006/jmcc.1997.0588.
46. Tscheschner H., Meinhardt E., Schlegel P., Jungmann A., Lehmann L. H., Müller O. J., Most P., Katus H. A., Raake P. W. PLoS One. 2019, vol. 14 (4), p. e0215992. DOI 10.1371/journal.pone.0215992.
47. Dolphin A. C. The Journal of Physiology. 2016, vol. 594 (19), pp. 5369‒5390. DOI 10.1113/jp272262.
48. Wagner S., Maier L. S., Bers D. M. Circulation Research. 2015, vol. 116 (12), pp. 1956‒1970. DOI 10.1161/circresaha.116.304678.
49. Purohit A., Rokita A. G., Guan X., Chen B., Koval O. M., Voigt N., Neef S., Sowa T., Gao Z., Luczak E. D., Stefansdottir H., Behunin A. C., Li N., El-Accaoui R. N., Yang B., Swaminathan P. D., Weiss R. M., Wehrens X. H., Song L. S., Dobrev D., Maier L. S., Anderson M. E. Circulation. 2013, vol. 128 (16), pp. 1748‒1757. DOI 10.1161/circulationaha.113.003313.
50. Earm Y. E., Ho W. K., So I. Journal of Molecular and Cellular Cardiology. 1994, vol. 26 (2), pp. 163‒172. DOI 10.1006/jmcc.1994.1019.
51. Boucek R. J. Jr., Olson R. D., Brenner D. E., Ogunbunmi E. M., Inui M., Fleischer S. The Journal of Biological Chemistry. 1987, vol. 262 (33), pp. 15851‒15856. Available at: https://www.ncbi.nlm.nih.gov/pubmed/2890636.
52. Keung E. C., Toll L., Ellis M., Jensen R. A. The Journal of Clinical Investigation. 1991, vol. 87 (6), pp. 2108‒2113. DOI 10.1172/JCI115241.
53. Liang H., Li X., Li S., Zheng M. Q., Rozanski G. J. Journal of Molecular and Cellular Cardiology. 2008, vol. 44 (6), pp. 1062‒1071. DOI 10.1016/j.yjmcc.2008.03.011.
54. Chiamvimonvat N., O'Rourke B., Kamp T. J., Kallen R. G., Hofmann F., Flockerzi V., Marban E. Circulation Research. 1995, vol. 76 (3), pp. 325‒334. DOI 10.1161/01.res.76.3.325.
55. Hanna A. D., Lam A., Tham S., Dulhunty A. F., Beard N. A. Molecular Pharmacology. 2014, vol. 86 (4), pp. 438‒449. DOI 10.1124/mol.114.093849.
56. Song Y., Shryock J. C., Wagner S., Maier L. S., Belardinelli L. The Journal of Pharmacology and Experimental Therapeutics. 2006, vol. 318 (1), pp. 214‒222. DOI 10.1124/jpet.106.101832.
57. Wagner S., Ruff H. M., Weber S. L., Bellmann S., Sowa T., Schulte T., Anderson M. E., Grandi E., Bers D. M., Backs J., Belardinelli L., Maier L. S. Circulation Research. 2011, vol. 108 (5), pp. 555‒565. DOI 10.1161/CIRCRESAHA.110.221911.
58. Xie L. H., Chen F., Karagueuzian H. S., Weiss J. N. Circulation Research. 2009, vol. 104 (1), pp. 79‒86. DOI 10.1161/CIRCRESAHA.108.183475.

 

Дата создания: 19.10.2020 13:01
Дата обновления: 20.10.2020 11:34